TYPHOID VACCINE

Course overview

THERE ARE TWO UNITED STATES-LICENSED VACCINES AVAILABLE FOR SALMONELLA TYPHI, AN ORAL ATTENUATED LIVE VIRUS, AND AN INJECTABLE POLYSACCHARIDE VACCINE. THE FDA INDICATES BOTH VACCINES FOR INDIVIDUALS TRAVELING TO AN ENDEMIC ARE FROM A NON-ENDEMIC AREA. THEY ARE ALSO FDA-RECOMMENDED FOR INDIVIDUALS WITH HOUSEHOLD EXPOSURE TO A CHRONIC SALMONELLA TYPHI CARRIER OR ARE WORKING IN A LABORATORY SETTING WITH POTENTIALLY CONTAMINATED SPECIMENS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, METHODS AND TIMING OF ADMINISTRATION, SIGNIFICANT ADVERSE EFFECTS, CONTRAINDICATIONS, TOXICITY, AND MONITORING FOR TYPHOID VACCINE, SO PROVIDERS CAN ADMINISTER AND MONITOR THIS VACCINE IN CASES WHERE IT IS NEEDED.